- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.57 Å
- Oligo State
- hetero-1-1-1-1-mer
- Ligands
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x CA: CALCIUM ION(Non-covalent)
- 8 x GOL: GLYCEROL(Non-functional Binders)
GOL.9: 11 residues within 4Å:- Chain A: A.140, P.141, S.144, S.201, I.202, K.203, Y.204, Q.207
- Chain D: T.28, S.31, F.32
4 PLIP interactions:3 interactions with chain A, 1 interactions with chain D- Hydrogen bonds: A:I.202, A:Q.207, A:Q.207, D:T.28
GOL.10: 9 residues within 4Å:- Chain A: F.21, W.93, A.96, P.110, L.111, F.159
- Chain B: K.260, L.261, G.263
4 PLIP interactions:1 interactions with chain A, 3 interactions with chain B- Hydrogen bonds: A:F.159, B:K.260, B:L.261, B:G.263
GOL.11: 6 residues within 4Å:- Chain A: R.211, T.212, A.213
- Ligands: NAG-NAG-BMA-MAN-MAN.4, NAG-NAG-BMA-MAN-MAN.4, NAG-NAG-BMA-MAN-MAN.4
1 PLIP interactions:1 interactions with chain A- Water bridges: A:R.211
GOL.12: 8 residues within 4Å:- Chain A: F.337, R.339, Y.364, K.369
- Chain B: P.267, N.268, D.269, Q.293
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:R.339, A:R.339, B:Q.293
GOL.18: 8 residues within 4Å:- Chain B: A.321, K.322, I.324, P.325, G.326, A.327, E.355, K.384
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:K.322, B:G.326, B:A.327, B:K.384
GOL.19: 7 residues within 4Å:- Chain B: V.61, I.63, P.85, L.88, T.99, L.100, Q.101
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:Q.101, B:Q.101
GOL.22: 10 residues within 4Å:- Chain A: Y.80, E.117, M.118
- Chain C: Y.32, G.91, N.92, Y.96
- Chain D: F.99, R.102, G.103
4 PLIP interactions:2 interactions with chain C, 2 interactions with chain A- Hydrogen bonds: C:N.92, C:Y.96, A:Y.80, A:Y.80
GOL.23: 6 residues within 4Å:- Chain C: G.42
- Chain D: V.93, Y.95, Q.110, G.111, S.113
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:Y.95, D:S.113
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x 01: (2S)-phenyl{(3S)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl}acetic acid
01.16: 19 residues within 4Å:- Chain A: D.150, F.177, Y.178, Q.180, T.212, A.213, A.215, D.218
- Chain B: S.121, A.122, S.123, I.179, A.213, N.214, I.215, D.216, T.217, E.219
- Ligands: MG.13
11 PLIP interactions:5 interactions with chain A, 6 interactions with chain B- Hydrophobic interactions: A:Y.178, A:Y.178, A:T.212, B:A.122
- Hydrogen bonds: A:Q.180, A:D.218, B:S.121, B:A.122, B:N.214, B:N.214, B:N.214
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
- 2 x ACT: ACETATE ION(Non-functional Binders)
ACT.20: 8 residues within 4Å:- Chain B: R.73, E.108, D.109, S.143, K.144, L.145, T.146, S.147
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:S.143
ACT.24: 7 residues within 4Å:- Chain A: V.199, I.202, K.203
- Chain C: H.55
- Chain D: L.100, D.106, Y.107
7 PLIP interactions:5 interactions with chain D, 2 interactions with chain A- Hydrophobic interactions: D:L.100, D:D.106, D:Y.107
- Hydrogen bonds: D:Y.107, D:Y.107, A:K.203
- Water bridges: A:K.203
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Harrison, B.A. et al., The Discovery of MORF-627, a Highly Selective Conformationally-Biased Zwitterionic Integrin alpha v beta 6 Inhibitor for Fibrosis. J.Med.Chem. (2024)
- Release Date
- 2024-11-13
- Peptides
- Integrin alpha-V heavy chain: A
Integrin beta-6: B
17E6 Fab light chain: C
17E6 Fab heavy chain: D - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.57 Å
- Oligo State
- hetero-1-1-1-1-mer
- Ligands
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x CA: CALCIUM ION(Non-covalent)
- 8 x GOL: GLYCEROL(Non-functional Binders)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x 01: (2S)-phenyl{(3S)-3-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butoxy]pyrrolidin-1-yl}acetic acid
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
- 2 x ACT: ACETATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Harrison, B.A. et al., The Discovery of MORF-627, a Highly Selective Conformationally-Biased Zwitterionic Integrin alpha v beta 6 Inhibitor for Fibrosis. J.Med.Chem. (2024)
- Release Date
- 2024-11-13
- Peptides
- Integrin alpha-V heavy chain: A
Integrin beta-6: B
17E6 Fab light chain: C
17E6 Fab heavy chain: D - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D